Large, real-world study finds Jada System safe, effective for postpartum hemorrhage
In the study, investigators analyzed the Jada System in 800 patients from October 2020 to April 2022 across 16 hospitals in the United States. Results of the study were presented at the SMFM 43rd Annual Pregnancy Meeting in San Francisco, California.
Azithromycin reduces risk of maternal sepsis, death in vaginal delivery
A single oral dose of azithromycin in women in labor planning vaginal delivery significantly reduced the risk of maternal death and sepsis, according to study results presented at the SMFM 43rd Annual Pregnancy Meeting.
Optimal prenatal opioid use disorder care may reduce odds of preterm birth
An oral concurrent session at SMFM’s 42nd Annual Pregnancy Meeting highlighted an analysis of pregnancy outcomes after optimal prenatal opioid use disorder care.
Marijuana use and morning sickness symptoms
An oral presentation at the Society for Maternal-Fetal Medicine’s (SMFM) 42nd Annual Pregnancy Meeting explored possible associations with marijuana use and nausea and vomiting in early pregnancy.
Prenatal genetic data sharing and privacy risks
An oral abstract presentation at SMFM’s 42nd Annual Pregnancy Meeting explored cfDNA testing and participants’ knowledge and willingness of genetic data sharing.
Michal Elovitz, MD, discusses new preterm birth data at SMFM
In this exclusive video interview, Michal Elovitz, MD, chief medical advisor at Mirvie, discusses the latest data from the RNA testing platform in predicting preterm birth at the SMFM 42nd Annual Pregnancy Meeting.
Early gestational diabetes screening in women at risk for gestational diabetes: a randomized controlled trial
Researchers presented a study at the SMFM 42nd Annual Pregnancy Meeting to assess if early gestational diabetes (GDM) screening is associated with improved perinatal outcomes.
Supporting transgender and gender-expansive individuals in reproductive health care
At the Society for Maternal-Fetal Medicine’s 42nd Annual Meeting, a roundtable discussion explored ways to promote inclusivity and support transgender and gender-expansive individuals in the women’s health space.
Exploring the maternal gut microbiome during the lactational period
Researchers presented their oral abstract on the association between lactation and the gut microbiome during the SMFM 42nd Annual Pregnancy Meeting.
Association of prenatal ultrasonographic findings with neonatal outcomes
At the 2022 virtual SMFM conference, a poster session highlighted a study on prenatal ultrasound findings in pregnant women with SARS-CoV-2 infection.
Register for SMFM's 42nd Annual Pregnancy Meeting
Registration is now open for the Society for Maternal-Fetal Medicine's (SMFM) 42nd Annual Pregnancy Meeting, to be held from January 31 to February 5, 2022, at the Gaylord Palms Resort and Convention Center near Orlando, Florida.
17P to prevent preterm birth in women with HIV
This article is on based on information presented at the Society for Maternal-Fetal Medicine’s 2021 Virtual Annual Meeting, which was held Jan. 25 to Jan. 30.
Vitamin D and hypertensive disorders of pregnancy
Inflammatory mediators and pain in endometriosis
For treating inflammatory pain in endometriosis, inflammatory factors that promote angiogenesis and neuroangiogenesis are encouraging targets, according to a systematic review in the journal Biomedicines.
Menopausal symptoms associated with premature ovarian insufficiency
A prospective study from the People’s Republic of China has concluded that menopausal symptoms in women with premature ovarian insufficiency (POI) were significantly higher than in women with natural menopause.
Chronic hypertension in women with pregestational diabetes
Hypertension and persistent inflammation with prior preeclampsia
Augmenting/replacing obstetric comorbidity index with L&D features
“We are very concerned about increases in SMM noted in recent years in the United States,” said principal investigator Dena Goffman, MD.
Daily vs. intermittent iron therapy in pregnant patients
Quality initiatives for decreasing racial disparities in maternal morbidity
Placental transfer of SARS-CoV-2 specific antibodies from mothers to newborns
This article is on based on information presented at the Society for Maternal-Fetal Medicine’s 2021 Virtual Annual Meeting, which will be held from Jan. 25 to Jan. 30.
Pregnancy-related deaths: 2009-2018
Florida’s Pregnancy Related Mortality Ratio (PRMR) shows a significant decrease in pregnancy-related mortality rates among Hispanic and non-Hispanic Black women, according to a study presented at SMFM’s 2021 Virtual Annual Meeting.
Six vs. Twelve hours of Foley catheter placement
Severity of COVID-19 Determines Likelihood of Pregnancy Complications
This article is on based on information presented at the Society for Maternal-Fetal Medicine’s 2021 Virtual Annual Meeting, which is being held from Jan. 25 to Jan. 30.
Social determinants of health in preterm birth of non-Hispanic Black women
Practicing equitable global health
“Whatever you do for me but without me, you do against me.” That was the theme of a scientific forum on Wednesday titled, “Practicing equitable global health,” as part of SMFM’s 2021 Virtual Annual Meeting.
Blood Pressure Measurements Affected by Location
Blood pressure (BP) measurements are higher when taken at alternative locations like the wrist and forearm, according to a prospective study of pregnant patients.
Systemic Racism Persists in OB/GYN Care
This article is on based on information presented at the Society for Maternal-Fetal Medicine’s 2021 Virtual Annual Meeting, which is being held Jan. 25 to Jan. 30.
TXA for postpartum hemorrhage prevention after cesarean
Loïc Sentilhes, MD, PHD, presented data on tranexamic acid (TXA) for the prevention of postpartum hemorrhage after cesarean delivery: the TRAAP2 trial, on Wednesday at SMFM's 2021 Virtual Annual Meeting.
Opioids and Obstetrics: Substance use disorders in pregnancy
Rates of pregnancy complications due to opioid use disorder quadrupled from 1999 to 2014, according to data from Townsel’s presentation, which resulted in four times as many infants born with neonatal abstinence syndrome (NAS) in 2014 than in 1999.
2 Clarke Drive Cranbury, NJ 08512